Division of Strategic Planning and Evaluation Research Program on Emerging and Re-emerging Infectious Diseases

The aim of this program is to strengthen comprehensively the countermeasures against infectious diseases to prevent people in Japan and the world from infectious diseases; thus, contributing to overcome the public health problems. To achieve this issue, the program  supports to promote domestic and global infectious disease R&D, including basic research, basic manufacturing technologies, and research for practical applications (such as developing the diagnostics, treatments, and preventions) that contribute to control infectious diseases.

PS (Program Supervisor)

• WAKITA Takaji, Director-General, National Institute of Infectious Diseases

PO (Program Officer)

• KANDA Tadahito, Honorary Staff Member, National Institute of Infectious Diseases
• KURANE Ichiro, Honorary Staff Member, National Institute of Infectious Diseases
• NAKAJIMA Kensuke, Professor, Nagasaki University
• HIRAI Keiji, Outside Director, Fuji Pharma Co.,Ltd.
• HIRAYAMA Toshiya, Professor Emeritus, Nagasaki University
• MORI Toru, Director Emeritus, The Research Institute of Tuberculosis, Japan Anti-tuberculosis Association
• YAMANO Yoshinori, Chief Scientific Officer for Infectious Diseases, Shionogi & Co., Ltd.

Therapeutic drug development program for COVID-19

PS (Program Supervisor)

• MATSUMOTO Tetsuya, Professor, International University of Health and Welfare

PO (Program Officer)

• AKASHI Toshi, Professor, Kyushu University of Health and Welfare
• TAWARA Shuichi, Professor, Okayama University of Science
• YAMAGUCHI Teruhide, Professor, Kanazawa Institute of Technology
• YAMASHITA Makoto, Professor, Aichi Medical University